
Pulse Biosciences PLSE
$ 25.89
1.29%
Quarterly report 2026-Q1
added 05-14-2026
Pulse Biosciences Interest Expense 2011-2026 | PLSE
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Pulse Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -52 K | -18 K | - | - | - | - | 983 K | 418 K | 247 K | 68 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 983 K | -52 K | 274 K |
Quarterly Interest Expense Pulse Biosciences
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24 K | -19 K | - | - | - | -1 K | - | - | - | - | - | - | - | - | - | - | - | - | 517 K | 114 K | - | 9 K | 21 K | 78 K | 143 K | 218 K | 290 K | 332 K | 107 K | 118 K | 137 K | 56 K | 128 K | 39 K | 41 K | 39 K | 34 K | 31 K | 3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 517 K | -24 K | 105 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Glaukos Corporation
GKOS
|
479 K | $ 120.23 | -13.52 % | $ 6.88 B | ||
|
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
-16.4 M | $ 62.55 | -0.48 % | $ 12.5 B | ||
|
Alcon
ALC
|
204 M | $ 67.78 | -0.22 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
9.91 K | $ 4.1 | -0.97 % | $ 189 M | ||
|
LeMaitre Vascular
LMAT
|
5.18 M | $ 97.75 | -1.78 % | $ 2.21 B | ||
|
ICU Medical
ICUI
|
93.3 M | $ 133.31 | 1.52 % | $ 3.28 B | ||
|
iRhythm Technologies
IRTC
|
5.44 M | $ 116.56 | -1.11 % | $ 3.73 B | ||
|
Masimo Corporation
MASI
|
300 K | $ 178.81 | 0.1 % | $ 9.53 B | ||
|
Ekso Bionics Holdings
EKSO
|
-26 K | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
60.3 K | $ 0.38 | -1.77 % | $ 31.2 M | ||
|
electroCore
ECOR
|
14.9 K | $ 6.67 | 11.35 % | $ 56.6 K | ||
|
Envista Holdings Corporation
NVST
|
-2.3 M | $ 23.43 | -0.85 % | $ 3.94 B | ||
|
Haemonetics Corporation
HAE
|
-28.7 M | $ 65.49 | 5.73 % | $ 3.09 B | ||
|
Isoray
ISR
|
84 K | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
8.4 M | $ 216.57 | -1.41 % | $ 21.3 B | ||
|
STAAR Surgical Company
STAA
|
2.25 M | $ 32.47 | -0.98 % | $ 1.61 B | ||
|
InfuSystem Holdings
INFU
|
2 K | $ 9.66 | -2.82 % | $ 200 M | ||
|
Microbot Medical
MBOT
|
-5 K | $ 1.71 | -3.93 % | $ 78.3 M | ||
|
Teleflex Incorporated
TFX
|
85.1 M | $ 132.75 | 0.9 % | $ 5.92 B | ||
|
Merit Medical Systems
MMSI
|
-2.39 M | $ 64.17 | 0.85 % | $ 3.8 B | ||
|
Utah Medical Products
UTMD
|
-120 K | $ 64.51 | -0.74 % | $ 209 M | ||
|
West Pharmaceutical Services
WST
|
-1 M | $ 316.42 | 0.09 % | $ 22.9 B | ||
|
DENTSPLY SIRONA
XRAY
|
24 M | $ 10.21 | 2.82 % | $ 2.04 B | ||
|
Retractable Technologies
RVP
|
152 K | $ 0.71 | 5.46 % | $ 21.3 M | ||
|
Pro-Dex
PDEX
|
533 K | $ 63.52 | 1.45 % | $ 209 M | ||
|
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
1.82 M | $ 23.95 | -3.19 % | $ 1.14 B | ||
|
Stereotaxis
STXS
|
2 K | $ 1.92 | 1.05 % | $ 175 M | ||
|
Baxter International
BAX
|
290 M | $ 19.18 | 0.79 % | $ 9.84 B | ||
|
ResMed
RMD
|
3.2 M | $ 208.05 | -0.45 % | $ 30.4 B | ||
|
AtriCure
ATRC
|
683 K | $ 28.29 | -1.84 % | $ 1.35 B | ||
|
Harvard Bioscience
HBIO
|
-2.66 M | $ 5.59 | 1.27 % | $ 248 M | ||
|
AngioDynamics
ANGO
|
4.94 M | $ 11.92 | -0.33 % | $ 487 M | ||
|
Becton, Dickinson and Company
BDX
|
613 M | $ 147.63 | 0.94 % | $ 42.5 B | ||
|
Nephros
NEPH
|
-78 K | $ 3.47 | -5.96 % | $ 36.8 M | ||
|
OraSure Technologies
OSUR
|
229 K | $ 3.61 | 9.73 % | $ 265 M | ||
|
Repligen Corporation
RGEN
|
2.82 M | $ 115.06 | 1.49 % | $ 6.47 M |